<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F11E21C9-E05F-4173-939C-61F868FE1FBA"><gtr:id>F11E21C9-E05F-4173-939C-61F868FE1FBA</gtr:id><gtr:name>The Wellcome Trust Ltd</gtr:name><gtr:address><gtr:line1>215 Euston Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:department>Grants and Contracts Support Office</gtr:department><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F11E21C9-E05F-4173-939C-61F868FE1FBA"><gtr:id>F11E21C9-E05F-4173-939C-61F868FE1FBA</gtr:id><gtr:name>The Wellcome Trust Ltd</gtr:name><gtr:address><gtr:line1>215 Euston Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/88F7DF72-30DB-4063-9694-23BE65CA692B"><gtr:id>88F7DF72-30DB-4063-9694-23BE65CA692B</gtr:id><gtr:firstName>Alister</gtr:firstName><gtr:otherNames>Gordon</gtr:otherNames><gtr:surname>Craig</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0400417"><gtr:id>A6BED6C7-D52F-4034-B202-A64C719F8829</gtr:id><gtr:title>An analysis of ICAM-1 adhesion in P.falciparum malaria</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400417</gtr:grantReference><gtr:abstractText>With 300 to 500 million infections worldwide every year, malaria ranks as one of the major infectious diseases of developing countries. The processes by which this disease progresses to severe symptoms are poorly understood but with 1-2 million deaths every year from malaria, mainly in children under five in sub-Saharan Africa, their elucidation is a priority. Of the four species of the human malaria parasites, Plasmodium falciparum is unique in being able to promote the attachment of infected red blood cells to cells lining small blood vessels in the host. It is thought that this adhesive property is associated with the development of life-threatening symptoms.
 This study sets out to examine how malaria parasites from clinical samples bind to human cells and to understand the attributes of P.falciparum that allow it to do this. One of the problems is that unlike most pathogenic organisms, P.falciparum is able to stick to a range of host receptors so part of the question being addressed is whether one of these, intercellular adhesion molecule-1 (or ICAM-1) , is particularly involved in the progression to severe disease rather than the mild symptoms seen in most infections. 
With the resources generated from the clinical study we will be able to examine the molecular events taking place during sequestration, leading to the identification of the binding site on the P.falciparum-infected red blood cell and the development of new interventions aimed at preventing severe malaria. By understanding how infected red blood cells and host cells interact, we can design chemicals that will interfere with this process for the treatment of acute malaria infection, but also we will be able to investigate whether children can be immunised against types of malaria parasites that cause severe disease. The latter ?anti-disease? strategy would reduce mortality from malaria while allowing people in malaria endemic countries to still develop the naturally-acquired immunity that protects them throughout their adult lives. 
Both the Liverpool School of Tropical Medicine (LSTM) and Kenyan sites are commited to the involvement of people from developing countries in research, in terms of technology transfer and education and also in communicating their results to the community at large. Both have a strong and long-term commitment to ?promote improved health, particularly for people of the less developed countries in the tropics and sub-tropics? (LSTM Mission Statement).</gtr:abstractText><gtr:technicalSummary>P.falciparum malaria is one of the three major infectious diseases of developing countries, causing over 1 million deaths per year and inflicting a heavy burden economically on some of the poorest regions in the world. Malaria is a complex disease, encompassing a number of severe syndromes such as malarial anaemia and host organ failure (including cerebral malaria). The basis for pathogenesis is not known but the unique ability of P.falciparum (amongst human malaria parasites) to cause sequestration of mature infected erythrocytes from the peripheral circulation by cytoadherence to small vessel endothelium is thought to be a major component. Our understanding of the molecular events involved in primary adhesion is relatively well developed but the relationship between specific receptor usage and disease is not. Data on this latter point have been conflicting but there are several lines of evidence that support ICAM-1 as having a role in pathogenesis. 
The aims of this study are 
? to analyse the role of ICAM-1 adhesion in causing severe malaria in children. 
? to link this clinical study with a molecular analysis of the corresponding binding site for ICAM-1 on the parasite ligand PfEMP1, leading to the identification of a consensus for the binding site on PfEMP1 
These will incorporate binding assays under static and flow conditions using protein and cell-based targets as well as molecular and bioinformatics techniques. This will allow us to evaluate the impact of ICAM-1-based, anti-adhesive interventions, by defining the prevalence of ICAM-1 binding in patient isolates and its association with severe disease and contribute to the development of anti-disease vaccines and drugs based on inhibition of cytoadherence through characterisation of the binding site on the infected erythrocyte.</gtr:technicalSummary><gtr:fund><gtr:end>2009-10-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>544045</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>KEMRI-Wellcome Trust Research Programme</gtr:department><gtr:description>KEMRI-Kilifi</gtr:description><gtr:id>5E2AF43C-6492-412B-881B-5291FDC859AC</gtr:id><gtr:impact>No outputs as yet.</gtr:impact><gtr:partnerContribution>Joint PhD studentships</gtr:partnerContribution><gtr:piContribution>Adhesion assay training and scientific support for PhD students</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Community</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>39C359E6-EEF2-473F-860A-6B618DE149EE</gtr:id><gtr:impact>1. Links (and membership) with local Rotary organisation by lead researcher in Kenya. 2. Presentation to academics visiting the Kilifi site.

Strong relationship between local population in Kilifi with resreach unit.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>190000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>CBFE0967-A07A-454F-A47E-06AA6C307D5B</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigator Award</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>C2D54D87-73F2-4C90-BE9C-932F7ADE15FE</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>282537</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Early induction of pro-adhesive state by P.falciparum cytoadherence)</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>1645BBB3-A7F6-43F1-8A4C-B9673E947392</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Training of early stage researchers in Kenya</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>356850EB-55E0-4922-AA93-94DB19C76C57</gtr:id><gtr:impact>Post-graduates have been trained through association with the study in Kenya.; One post-graduate researcher has gone on to do a PhD and another application has recently been made to an EU-funded scheme.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New laboratory adapted P. falciparum isolates selected for binding to ICAM-1.</gtr:description><gtr:id>0C9366B0-FF1F-450C-99F9-67A4DD6EFFF2</gtr:id><gtr:impact>We are currently analysing the molecular and cell-biology signatures of these new parasite isolates.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ICAM-1-binding IE</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Influence of mycoplasma infection in P.falciparum cultures on adhesion assays.</gtr:description><gtr:id>E75EE1A1-5D4F-4500-B9BA-4FA39C138FFB</gtr:id><gtr:impact>Need to ensure screening for mycoplasma</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Adhesion assay development</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF6DD6EB-10E2-47A3-BB26-CFC6B8266442"><gtr:id>AF6DD6EB-10E2-47A3-BB26-CFC6B8266442</gtr:id><gtr:title>Cytoadherence and virulence - the case of Plasmodium knowlesi malaria.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4c88181fd6c1d5b00c99619b57079799"><gtr:id>4c88181fd6c1d5b00c99619b57079799</gtr:id><gtr:otherNames>Fatih FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66F7D6AE-FCE4-44A2-8060-8CE3952827EB"><gtr:id>66F7D6AE-FCE4-44A2-8060-8CE3952827EB</gtr:id><gtr:title>Differential var gene expression in the organs of patients dying of falciparum malaria.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3e9ee7bb3cb33759fa595e31fe33f9c7"><gtr:id>3e9ee7bb3cb33759fa595e31fe33f9c7</gtr:id><gtr:otherNames>Montgomery J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32C6B4A5-AC0B-427C-AC89-916D719F8B9C"><gtr:id>32C6B4A5-AC0B-427C-AC89-916D719F8B9C</gtr:id><gtr:title>Evidence of promiscuous endothelial binding by Plasmodium falciparum-infected erythrocytes.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d12959b3c4878a87581c82d92d48fae6"><gtr:id>d12959b3c4878a87581c82d92d48fae6</gtr:id><gtr:otherNames>Esser C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6125A0D3-5F30-428F-94B4-27FCC95B5BC1"><gtr:id>6125A0D3-5F30-428F-94B4-27FCC95B5BC1</gtr:id><gtr:title>Cerebral malaria pathogenesis: revisiting parasite and host contributions.</gtr:title><gtr:parentPublicationTitle>Future microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d01b15caf0ac8fad9d4d7ab24523c6f"><gtr:id>1d01b15caf0ac8fad9d4d7ab24523c6f</gtr:id><gtr:otherNames>Grau GE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1746-0913</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB12E00E-3BD7-4F5C-838E-885002B33279"><gtr:id>FB12E00E-3BD7-4F5C-838E-885002B33279</gtr:id><gtr:title>Competitive endothelial adhesion between Plasmodium falciparum isolates under physiological flow conditions.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/41ce9793a31eefefc1a2d000f2ef6632"><gtr:id>41ce9793a31eefefc1a2d000f2ef6632</gtr:id><gtr:otherNames>Phiri H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F71F0928-25B6-429F-900D-70FACF07502C"><gtr:id>F71F0928-25B6-429F-900D-70FACF07502C</gtr:id><gtr:title>Cytoadherence and severe malaria.</gtr:title><gtr:parentPublicationTitle>The Malaysian journal of medical sciences : MJMS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8d0b4918307e855f13e128315c7445c3"><gtr:id>8d0b4918307e855f13e128315c7445c3</gtr:id><gtr:otherNames>Craig AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1394-195X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ED1942EF-888B-4ADB-85F4-DC09EEDAC926"><gtr:id>ED1942EF-888B-4ADB-85F4-DC09EEDAC926</gtr:id><gtr:title>Altered phenotype and gene transcription in endothelial cells, induced by Plasmodium falciparum-infected red blood cells: pathogenic or protective?</gtr:title><gtr:parentPublicationTitle>International journal for parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/605847a447e7f8075fa8cdb7fe82ffc3"><gtr:id>605847a447e7f8075fa8cdb7fe82ffc3</gtr:id><gtr:otherNames>Chakravorty SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0020-7519</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8DEF351-E89B-4DFE-A361-32681448926A"><gtr:id>E8DEF351-E89B-4DFE-A361-32681448926A</gtr:id><gtr:title>Sequence variation of PfEMP1-DBLalpha in association with rosette formation in Plasmodium falciparum isolates causing severe and uncomplicated malaria.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/24e3ca7fa2f76b3df0319fbf82c74ef0"><gtr:id>24e3ca7fa2f76b3df0319fbf82c74ef0</gtr:id><gtr:otherNames>Horata N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11275A6C-D7B3-497D-B4F2-F60FAF3C5197"><gtr:id>11275A6C-D7B3-497D-B4F2-F60FAF3C5197</gtr:id><gtr:title>Vascular endothelial cells cultured from patients with cerebral or uncomplicated malaria exhibit differential reactivity to TNF.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/566b37eb09f7af69011150f77490f379"><gtr:id>566b37eb09f7af69011150f77490f379</gtr:id><gtr:otherNames>Wassmer SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C08737A2-5230-42A9-B53B-139BC44963E5"><gtr:id>C08737A2-5230-42A9-B53B-139BC44963E5</gtr:id><gtr:title>Automated counting for Plasmodium falciparum cytoadherence experiments.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/680e576cd1e735084d107c739a8bf15d"><gtr:id>680e576cd1e735084d107c739a8bf15d</gtr:id><gtr:otherNames>Paton D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CA173867-87FD-4FDD-A2CF-DB5A34D37831"><gtr:id>CA173867-87FD-4FDD-A2CF-DB5A34D37831</gtr:id><gtr:title>Disruption of rosetting in Plasmodium falciparum malaria with chemically modified heparin and low molecular weight derivatives possessing reduced anticoagulant and other serine protease inhibition activities.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/525f0aa9b75a329ba02b752c076c7854"><gtr:id>525f0aa9b75a329ba02b752c076c7854</gtr:id><gtr:otherNames>Skidmore MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF395FBD-6155-43E9-95E8-4FEFC744432E"><gtr:id>AF395FBD-6155-43E9-95E8-4FEFC744432E</gtr:id><gtr:title>Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f47aebe3ea07af3a0da18d227e2c048"><gtr:id>0f47aebe3ea07af3a0da18d227e2c048</gtr:id><gtr:otherNames>Larkin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D63E77A7-731C-44A1-B924-1565693481F1"><gtr:id>D63E77A7-731C-44A1-B924-1565693481F1</gtr:id><gtr:title>Continued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment.</gtr:title><gtr:parentPublicationTitle>Molecular and biochemical parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b75403f60e5d6fe73258a2f20e3bc889"><gtr:id>b75403f60e5d6fe73258a2f20e3bc889</gtr:id><gtr:otherNames>Hughes KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0166-6851</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20636CF0-2E5A-4D72-AC16-D99193C37533"><gtr:id>20636CF0-2E5A-4D72-AC16-D99193C37533</gtr:id><gtr:title>Plasmodium falciparum intercellular adhesion molecule-1-based cytoadherence-related signaling in human endothelial cells.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/289b9d4667edbc785df01c96a10d4abd"><gtr:id>289b9d4667edbc785df01c96a10d4abd</gtr:id><gtr:otherNames>Jenkins N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9560656E-87B7-4371-99AA-4C0167625474"><gtr:id>9560656E-87B7-4371-99AA-4C0167625474</gtr:id><gtr:title>Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/88e08d7d2a74852b2d01b7d90497de31"><gtr:id>88e08d7d2a74852b2d01b7d90497de31</gtr:id><gtr:otherNames>Ochola LB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44861E83-DC47-49D0-B014-39F0346302CE"><gtr:id>44861E83-DC47-49D0-B014-39F0346302CE</gtr:id><gtr:title>Pathogenesis of cerebral malaria--inflammation and cytoadherence.</gtr:title><gtr:parentPublicationTitle>Frontiers in cellular and infection microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/862d548ee4f86bc4336b98ad3f85ffa7"><gtr:id>862d548ee4f86bc4336b98ad3f85ffa7</gtr:id><gtr:otherNames>Storm J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2235-2988</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E330C803-B378-42A4-AD43-D3A825914CB2"><gtr:id>E330C803-B378-42A4-AD43-D3A825914CB2</gtr:id><gtr:title>Erythrocytic casein kinase II regulates cytoadherence of Plasmodium falciparum-infected red blood cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2e151acaf5feedcc3ed65f243ee47545"><gtr:id>2e151acaf5feedcc3ed65f243ee47545</gtr:id><gtr:otherNames>Hora R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82D5893F-4DA1-4381-A624-FBAF725583A2"><gtr:id>82D5893F-4DA1-4381-A624-FBAF725583A2</gtr:id><gtr:title>Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c49a58743b29caa3e0a38641316a7bc3"><gtr:id>c49a58743b29caa3e0a38641316a7bc3</gtr:id><gtr:otherNames>Bridges DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C62DEE2F-4C54-40E2-A8D0-1FA4BD54EB67"><gtr:id>C62DEE2F-4C54-40E2-A8D0-1FA4BD54EB67</gtr:id><gtr:title>Identification of phosphorylated proteins in erythrocytes infected by the human malaria parasite Plasmodium falciparum.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e1ae91a136cc1808e002adb45e242f69"><gtr:id>e1ae91a136cc1808e002adb45e242f69</gtr:id><gtr:otherNames>Wu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0F0211F1-AFB5-4691-A0C3-19E162F62F59"><gtr:id>0F0211F1-AFB5-4691-A0C3-19E162F62F59</gtr:id><gtr:title>An analysis of the binding characteristics of a panel of recently selected ICAM-1 binding Plasmodium falciparum patient isolates.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e20b30d092a3bd63e226dfd6981a5e3b"><gtr:id>e20b30d092a3bd63e226dfd6981a5e3b</gtr:id><gtr:otherNames>Madkhali AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E6452E97-CC8F-46A4-A257-E48CEA55178E"><gtr:id>E6452E97-CC8F-46A4-A257-E48CEA55178E</gtr:id><gtr:title>Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea95bb50482d79804d8d24c1fdb33849"><gtr:id>ea95bb50482d79804d8d24c1fdb33849</gtr:id><gtr:otherNames>Maier AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F52BAC38-02A0-4447-9335-129BE4E3EEC9"><gtr:id>F52BAC38-02A0-4447-9335-129BE4E3EEC9</gtr:id><gtr:title>The role of animal models for research on severe malaria.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8d0b4918307e855f13e128315c7445c3"><gtr:id>8d0b4918307e855f13e128315c7445c3</gtr:id><gtr:otherNames>Craig AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/24B8F314-08EB-4A2D-AA17-85C9CC029335"><gtr:id>24B8F314-08EB-4A2D-AA17-85C9CC029335</gtr:id><gtr:title>Continued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment.</gtr:title><gtr:parentPublicationTitle>Molecular and biochemical parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b75403f60e5d6fe73258a2f20e3bc889"><gtr:id>b75403f60e5d6fe73258a2f20e3bc889</gtr:id><gtr:otherNames>Hughes KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0166-6851</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6DD0C0DD-C6DB-4D8C-B874-13A66AE1657B"><gtr:id>6DD0C0DD-C6DB-4D8C-B874-13A66AE1657B</gtr:id><gtr:title>Signal transduction in Plasmodium-Red Blood Cells interactions and in cytoadherence</gtr:title><gtr:parentPublicationTitle>ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/deb99cae383d5f5fe4479e7dffc93210"><gtr:id>deb99cae383d5f5fe4479e7dffc93210</gtr:id><gtr:otherNames>Cruz Laura N.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0001-3765</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400417</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>